Showing results (641-650 of 834) with videos related to

Sort By:
Pageof 84
Cancer Research|October 10, 2014
MHC-restricted phosphopeptides from insulin receptor substrate-2 and CDC25b offer broad-based immunotherapeutic agents for cancerAngela L Zarling, Rebecca C Obeng, A Nicole Desch, et al.
Alzheimer'S & Dementia (New York, N. Y.)|December 21, 2020
Safety and tolerability of GRF6019 in mild-to-moderate Alzheimer's disease dementiaJonas Hannestad, Katie Koborsi, Vicki Klutzaritz, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 8, 2017
Emergence of dalbavancin non-susceptible, vancomycin-intermediate Staphylococcus aureus (VISA) after treatment of MRSA central line-associated bloodstream infection with a dalbavancin- and vancomycin-containing regimenB J Werth, R Jain, A Hahn, et al.
Archives of Neurology|July 15, 2009
Apathy symptom profile and behavioral associations in frontotemporal dementia vs dementia of Alzheimer typeTiffany W Chow, Malcolm A Binns, Jeffrey L Cummings, et al.
Plos One|December 3, 2019
Effect of dietary cellulose supplementation on gut barrier function and apoptosis in a murine model of endotoxemiaValentina Di Caro, Alicia M Alcamo, Jessica L Cummings, et al.
Neurology|June 12, 2002
Utility of clinical criteria in differentiating frontotemporal lobar degeneration (FTLD) from ADHoward J Rosen, K M Hartikainen, W Jagust, et al.
The Journal of Prevention of Alzheimer'S Disease|January 1, 2026
Tau in Alzheimer's disease: Shaping the future patient journeyCatherine J Mummery, Christopher Chen Li-Hsian, Cristian A Lasagna-Reeves, et al.
Journal of the International Neuropsychological Society : JINS|February 14, 2014
The "Alzheimer's type" profile of semantic clustering in amnestic mild cognitive impairmentPaula M McLaughlin, Matthew J Wright, Michael Larocca, et al.
Pageof 84